Concepedia
Statistics
Publications
20
Citations
2.3K
H-Index
17
Active since
1994
Affiliations
Granta Design (United Kingdom)(Current)
University of Liverpool
MRC Laboratory of Molecular Biology
United States Food and Drug Administration
Andrew Potter is an author at Granta Design (United Kingdom) specializing in medicinal chemistry, pharmacy, and drug discovery.
Publications per year
1994–2021
Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening
Nicolas Foloppe, Lisa M. Fisher, Rob Howes et al. · Bioorganic & Medicinal Chemistry · 2006 · 363 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
Jean Kim, Tiffany Farchione, Andrew Potter et al. · New England Journal of Medicine · 2019 · 329 citations
Pharmacy, Pharmacotherapy, Psychiatry +16
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 286 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic “Hot Spots”
Ben Davis, Mohammad Afshar, Gabriele Varani et al. · Journal of Molecular Biology · 2004 · 156 citations
Life Sciences, Medicinal Chemistry, Molecular Biology +16
1–5 of 20